RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles

Displaying items 13-24
  • Some companies are healthy, producing dividends

    You might conclude that stock dividends are harder to find these days than, say, a credit card company that forgives late payments. Cash-strapped companies, most notably banks, slashed dividends last year to the tune of more than $40 billion. It was the...
  • AstraZeneca and Mitsubishi Tanabe link on diabetes research

    LONDON (Reuters) - AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes. The deal will focus on early-stage research and the hope is...
  • U.S. clears AstraZeneca over heart drug trial

    LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects. The drugmaker...
  • U.S. investors switch out of Europe as recovery bet sours

    LONDON (Reuters) - U.S. investors are withdrawing billions of dollars from European stocks as signs of a stalled economic recovery, compounded by the Ukraine crisis, halt the past year's scramble to buy back into the region. The switch out of Europe into...
  • AstraZeneca starts final-stage tests on severe asthma drug

    LONDON (Reuters) - AstraZeneca said on Thursday it was starting final-stage Phase III clinical trials for its experimental drug tralokinumab as a treatment for severe asthma. The drug, which showed promising results in mid-stage trials in May, was...
  • Cash-strapped Kashkari gets creative in California governor's race

    SAN JOSE, Calif. As the summer wears on and the polls still show him far behind California Gov. Jerry Brown, Neel Kashkari is running the most energetic and high-profile campaign for governor that money can't buy. In 2010, billionaire Republican...
  • AstraZeneca compra derechos de negocio respiratorio de Almirall por hasta 2.110 mln dlr

    MADRID (Reuters) - Astrazeneca dio el miércoles un paso importante para ampliar su negocio respiratorio al llegar a un acuerdo para comprar al grupo español Almirall los derechos de sus medicamentos pulmonares por hasta 2.110 millones de dólares. El...
  • Pfizer supera pronósticos en 2do trim, no da información posible adquisición AstraZeneca

    (Reuters) - La farmacéutica estadounidense Pfizer Inc, que en mayo desistió de su intención de adquirir a su rival británica AstraZeneca Plc, dejó el martes a los inversores con la duda de si retomará sus intentos por comprar a su rival británica,...
  • Pfizer Slightly Beats Expectations, Leaves Investors Guessing About AstraZeneca

    Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals. The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
  • Pfizer supera pronósticos gracias a crecimiento tratamientos contra el cáncer

    (Reuters) - La farmacéutica estadounidense Pfizer Inc, que en mayo desistió de su intención de adquirir a su rival británica AstraZeneca Plc, reportó el martes ganancias por acción más altas a lo esperado para el segundo trimestre, ayudada por el...
  • Key Senate Democrat urges action to limit tax inversion 'virus'

    Key Senate Democrat urges action to limit tax inversion 'virus'
    A key Democratic senator on Tuesday decried the recent wave of American companies restructuring abroad to avoid U.S. taxes, describing it as a virus infecting the economy and urging legislation to halt it. But despite the call from Senate Finance...
  • Corporate tax scam watch: The 'inversion' craze

    Corporate tax scam watch: The 'inversion' craze
    Apple's done it. Herbalife has done it. Pfizer wanted to do it. What could be wrong with a corporate maneuver eyed by these fine, upstanding American corporations--and nearly 50 others in the last decade? The subject is "inversions," the catch-all...